โ† All Topics / ade

FDA ADE reports for Ropivacaine

ade_ropivacaine_adverse_events

ade en 2026-07-22

Ropivacaine โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Ropivacaine is a active ingredient.

Total reports

Ropivacaine: 29

Reports by species (top entries)

  • Cat 16
  • Dog 13

Top reported reactions (VEDDRA terms, top entries)

  • Behavioural disorder NOS 5
  • Hyperglycaemia 4
  • Lethargy (see also Central nervous system depression in Neurological) 4
  • Not eating 4
  • Peritonitis 4
  • Bradycardia 3
  • Death 3
  • Decreased haematocrit 3
  • Emesis 3
  • Fever 3

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b28.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).